Literature DB >> 31627876

The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.

Alessandro A Rizzo1, Dmitry M Korzhnev2.   

Abstract

DNA contains information that must be safeguarded, but also accessed for transcription and replication. To perform replication, eukaryotic cells use the B-family DNA polymerase enzymes Polδ and Polɛ, which are optimized for accuracy, speed, and processivity. The molecular basis of these high-performance characteristics causes these replicative polymerases to fail at sites of DNA damage (lesions), which would lead to genomic instability and cell death. To avoid this, cells possess additional DNA polymerases such as the Y-family of polymerases and the B-family member Polζ that can replicate over sites of DNA damage in a process called translesion synthesis (TLS). While able to replicate over DNA lesions, the TLS polymerases exhibit low-fidelity on undamaged DNA and, consequently, must be prevented from replicating DNA under normal circumstances and recruited only when necessary. The replicative bypass of most types of DNA lesions requires the consecutive action of these specialized TLS polymerases assembled into a dynamic multiprotein complex called the Rev1/Polζ mutasome. To this end, posttranslational modifications and a network of protein-protein interactions mediated by accessory domains/subunits of the TLS polymerases control the assembly and rearrangements of the Rev1/Polζ mutasome and recruitment of TLS proteins to sites of DNA damage. This chapter focuses on the structures and interactions that control these processes underlying the function of the Rev1/Polζ mutasome, as well as the development of small molecule inhibitors of the Rev1/Polζ-dependent TLS holding promise as a potential anticancer therapy.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer therapeutics; DNA damage tolerance; DNA polymerase; Protein structure; Protein-protein interactions; Translesion synthesis

Mesh:

Substances:

Year:  2019        PMID: 31627876      PMCID: PMC7229808          DOI: 10.1016/bs.enz.2019.07.001

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  179 in total

1.  DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes.

Authors:  X Zeng; D B Winter; C Kasmer; K H Kraemer; A R Lehmann; P J Gearhart
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

2.  Structural analysis of the conserved ubiquitin-binding motifs (UBMs) of the translesion polymerase iota in complex with ubiquitin.

Authors:  Daniel Burschowsky; Fabian Rudolf; Gwénaël Rabut; Torsten Herrmann; Matthias Peter; Peter Matthias; Gerhard Wider
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

3.  The Rev1 translesion synthesis polymerase has multiple distinct DNA binding modes.

Authors:  Frederik H de Groote; Jacob G Jansen; Yuji Masuda; Dipen M Shah; Kenji Kamiya; Niels de Wind; Gregg Siegal
Journal:  DNA Repair (Amst)       Date:  2011-07-12

4.  A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.

Authors:  Jessica L Wojtaszek; Nimrat Chatterjee; Javaria Najeeb; Azucena Ramos; Minhee Lee; Ke Bian; Jenny Y Xue; Benjamin A Fenton; Hyeri Park; Deyu Li; Michael T Hemann; Jiyong Hong; Graham C Walker; Pei Zhou
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

5.  Structural insights into the assembly of human translesion polymerase complexes.

Authors:  Wei Xie; Xuan Yang; Min Xu; Tao Jiang
Journal:  Protein Cell       Date:  2012-11-10       Impact factor: 14.870

6.  NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.

Authors:  Yulia Pustovalova; Mark W Maciejewski; Dmitry M Korzhnev
Journal:  J Mol Biol       Date:  2013-06-07       Impact factor: 5.469

Review 7.  Role of yeast Rad5 and its human orthologs, HLTF and SHPRH in DNA damage tolerance.

Authors:  Ildiko Unk; Ildikó Hajdú; András Blastyák; Lajos Haracska
Journal:  DNA Repair (Amst)       Date:  2010-01-21

Review 8.  Cisplatin: mode of cytotoxic action and molecular basis of resistance.

Authors:  Zahid H Siddik
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

9.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition.

Authors:  J Ross Chapman; Inger Brandsma; Guotai Xu; Jingsong Yuan; Martin Mistrik; Peter Bouwman; Jirina Bartkova; Ewa Gogola; Daniël Warmerdam; Marco Barazas; Janneke E Jaspers; Kenji Watanabe; Mark Pieterse; Ariena Kersbergen; Wendy Sol; Patrick H N Celie; Philip C Schouten; Bram van den Broek; Ahmed Salman; Marja Nieuwland; Iris de Rink; Jorma de Ronde; Kees Jalink; Simon J Boulton; Junjie Chen; Dik C van Gent; Jiri Bartek; Jos Jonkers; Piet Borst; Sven Rottenberg
Journal:  Nature       Date:  2015-03-23       Impact factor: 49.962

10.  Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes.

Authors:  Daili J A Netz; Carrie M Stith; Martin Stümpfig; Gabriele Köpf; Daniel Vogel; Heide M Genau; Joseph L Stodola; Roland Lill; Peter M J Burgers; Antonio J Pierik
Journal:  Nat Chem Biol       Date:  2011-11-27       Impact factor: 15.040

View more
  7 in total

1.  Nucleotide Excision Repair, XPA-1, and the Translesion Synthesis Complex, POLZ-1 and REV-1, Are Critical for Interstrand Cross-Link Repair in Caenorhabditis elegans Germ Cells.

Authors:  Sinae Oh; Woori Bae; Mohammad A Alfhili; Myon Hee Lee
Journal:  Biochemistry       Date:  2020-09-18       Impact factor: 3.162

2.  Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis.

Authors:  Kerry Silva McPherson; Angela M Zaino; Radha C Dash; Alessandro A Rizzo; Yunfeng Li; Bing Hao; Irina Bezsonova; M Kyle Hadden; Dmitry M Korzhnev
Journal:  ChemMedChem       Date:  2021-01-28       Impact factor: 3.466

3.  Human Rev1 relies on insert-2 to promote selective binding and accurate replication of stabilized G-quadruplex motifs.

Authors:  Amit Ketkar; Lane Smith; Callie Johnson; Alyssa Richey; Makayla Berry; Jessica H Hartman; Leena Maddukuri; Megan R Reed; Julie E C Gunderson; Justin W C Leung; Robert L Eoff
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 19.160

4.  Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.

Authors:  Nomi Pernicone; Maria Elias; Itay Onn; Dror Tobi; Tamar Listovsky
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

5.  DNA Polymerase ζ without the C-Terminus of Catalytic Subunit Rev3 Retains Characteristic Activity, but Alters Mutation Specificity of Ultraviolet Radiation in Yeast.

Authors:  Hollie M Siebler; Jian Cui; Sarah E Hill; Youri I Pavlov
Journal:  Genes (Basel)       Date:  2022-09-02       Impact factor: 4.141

Review 6.  Observing protein dynamics during DNA-lesion bypass by the replisome.

Authors:  Elise M Wilkinson; Lisanne M Spenkelink; Antoine M van Oijen
Journal:  Front Mol Biosci       Date:  2022-09-21

7.  Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells.

Authors:  Lu Ma; Xin Li; Xiaopeng Zhao; Haotong Sun; Feifei Kong; Yuanjie Li; Yu Sui; Fang Xu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.